Vivian Pinn Symposium Highlights Data and Women’s Health
May 15, 2025
Today, the NIH Office of Research on Women’s Health (ORWH) held its 9th Annual Vivian W. Pinn Symposium, bringing together experts in data science, women’s health, bioethics, artificial intelligence (AI), and health equity. While the symposium covered a broad range of topics, many discussions were highly relevant to autoimmune disease, particularly the ongoing need for more representative health data, better inclusion of women in research, and more personalized approaches to care.
ORWH Director Janine Clayton, M.D., FARVO, emphasized the importance of considering biological, social, and structural determinants of health when studying disease and designing care. Speakers repeatedly highlighted that health outcomes are shaped not only by genetics, but also by factors such as geography, socioeconomic status, access to care, and systemic inequities.
These themes are especially relevant to autoimmune disease, which disproportionately affects women and is often influenced by complex interactions between immune function, environmental exposures, stress, infection, access to care, and social determinants of health. Delayed diagnosis, underrepresentation in research, fragmented care, and disparities in outcomes remain major challenges across many autoimmune diseases.
The symposium’s capstone speaker, Raquel Hill, Ph.D., discussed how ZIP codes and lived environments can strongly predict health outcomes and life expectancy, arguing that biomedical research must better integrate environmental and socioeconomic data into electronic health records and research systems. She also addressed challenges involving privacy, underrepresentation, and data sharing for smaller populations.
Several presentations focused on improving representation in health research. Melissa Buffalo, M.S., CEO of the American Indian Cancer Foundation, discussed how small sample sizes and historical exclusion can make some communities effectively “invisible” in datasets, limiting meaningful analysis and contributing to health disparities. These concerns parallel longstanding issues in autoimmune disease research, where women, minority populations, and people with poorly understood or overlapping conditions are often underrepresented.
Other speakers explored how AI, longitudinal health data, microbiome research, and computational biology may help advance more individualized care. Liat Shenhav, Ph.D., presented research examining interactions between human milk, the infant microbiome, and immune-related outcomes such as asthma. Although not specifically focused on autoimmune disease, microbiome and early immune development research are increasingly being explored for their potential role in immune dysregulation and autoimmune risk.
Throughout the symposium, speakers also emphasized ethical data stewardship, patient trust, privacy protections, and the importance of including communities directly in research and decision-making processes. Vivian W. Pinn, M.D., closed the symposium by reiterating the importance of considering women’s health in trial design and ensuring that research findings are meaningfully shared with participating communities.